Retinoid expression (RARβ and CRBP1) in non-small-cell lung carcinoma;Retinoides (RARβ y CRBP1) en carcinoma de pulmon a celulas no pequeñas

Medicina

Volumn 68, Issue 3, 2008, Pages 205-212

  Mauro, Laura ^a   Dalurzo, Mercedes ^b   Smith, David ^b   Lastiri, Jose ^b   Vasallo, Bartolome ^b   De Kier Joffe, Elisa Bal ^a   Pallotta, Maria Guadalupe ^b   Puricelli, Lydia ^a  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

CRBP1; Immunohistochemistry; NSCLC; Prognostic marker; RAR ; Retinoids

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN 1; PROTEIN P53; RETINOIC ACID RECEPTOR BETA; CELLULAR RETINOL BINDING PROTEIN; RETINOIC ACID RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CELL LEVEL; CLINICAL ARTICLE; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TIME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, RETINOIC ACID; RETINOL-BINDING PROTEINS, CELLULAR; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 47549093392     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75: 191-202.
2. Stang A, Pohlabeln H, Muller KM, Jahn I, Giersiepen K, Jockel KH. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer 2006; 52: 29-36.
3. Thunnissen FB, Schuurbiers OC, den Bakker MA. A critical appraisal of prognostic and predictive factors for common lung cancers. Histopathology 2006; 48: 779-86.
4. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001; 1: 181-93.
5. Chambon P. A decade of molecular biology of retinoic acid receptors. Faseb J 1996; 10: 940-54.
6. Kuppumbatti YS, Rexer B, Nakajo S, Nakaya K, Mira-y-Lopez R. CRBP suppresses breast cancer cell survival and anchorage-independent growth. Oncogene 2001; 20: 7413-9.
7. Powell BL. Acute progranulocytic leukemia. Curr Opin Oncol 2001; 13: 8-13.
8. Nucifora E, Fantl D, Goldstein S, Kusminsky G. Acute promyelocytic leukemia: experience with trans-retinoic acid in Argentina. Medicina (Buenos Aires) 1996; 56: 333-8.
9. Kurie JM, Lotan R, Lee JJ, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst 2003; 95: 206-14.
10. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22: 7305-15.
11. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira y Lopez R. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 2002; 13: 335-41.
12. Mira y Lopez R, Zheng WL, Kuppumbatti YS, Rexer B, Jing Y, Ong DE. Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J Cell Physiol 2000; 185: 302-9.
13. Zhong C, Yang S, Huang J, Cohen MB, Roy-Burman P. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biol Ther 2003; 2: 179-84.
14. Brabender J, Metzger R, Salonga D, et al. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis 2005; 26: 525-30.
15. Mollard R, Ghyselinck NB, Wendling O, Chambon P, Mark M. Stage-dependent responses of the developing lung to retinoic acid signaling. Int J Dev Biol 2000; 44: 457-62.
16. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976; 35: 1332-8.
17. Dogra SC, Khanduja KL, Gupta MP. The effect of vitamin A deficiency on the initiation and postinitiation phases of benzo(a)pyrene-induced lung tumourigenesis in rats. Br J Cancer 1985; 52: 931-5.
18. Robbins ST, Fletcher AB. Early vs. delayed vitamin A supplementation in very-low-birth-weight infants. JPEN J Parenter Enteral Nutr 1993; 17: 220-5.
19. Xu XC, Sozzi G, Lee JS, et al. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997; 89: 624-9.
20. Khuri FR, Lotan R, Kemp BL, et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol 2000; 18: 2798-804.
21. Zelent A, Mendelsohn C, Kastner P, et al. Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. Embo J 1991; 10: 71-81.
22. Berard J, Gaboury L, Landers M, et al. Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR beta 4-like transgene. Embo J 1994; 13: 5570-80.
23. Berard J, Laboune F, Mukuna M, Masse S, Kothary R, Bradley WE. Lung tumors in mice expressing an antisense RARbeta2 transgene. Faseb J 1996; 10: 1091-7.
24. Petty WJ, Li N, Biddle A, et al. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 2005; 97: 1645-51.
25. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr 2004; 24: 201-21.
26. Fukunaka K, Saito T, Wataba K, Ashihara K, Ito E, Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol Hum Reprod 2001; 7: 437-46.
27. Chen GQ, Lin B, Dawson MI, Zhang XK. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells. Int J Cancer 2002; 99: 171-8.
28. Kim YH, Dohi DF, Han GR, et al. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res 1995; 55: 5603-10.
29. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira YLR. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000; 92: 475-80.
30. Jeronimo C, Henrique R, Oliveira J, et al. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 2004; 57: 872-6.
31. Farias EF, Ong DE, Ghyselinck NB, Nakajo S, Kuppumbatti YS, Mira y Lopez R. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 2005; 97: 21-9.
32. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995; 6: 1077-88.
33. Hatoum A, El-Sabban ME, Khoury J, Yuspa SH, Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001; 22: 1955-63.
34. Geradts J, Chen JY, Russell EK, Yankaskas JR, Nieves L, Minna JD. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ 1993; 4: 799-809.